Literature DB >> 29490017

Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart.

Yongzheng Guo1, Zhen Wang1, Xinghua Qin1, Jie Xu1, Zuoxu Hou1, Hongyan Yang1, Xuechao Mao1, Wenjuan Xing1, Xiaoliang Li2, Xing Zhang1, Feng Gao1.   

Abstract

Aims: Heart failure (HF) is characterized by reduced fatty acid (FA) utilization associated with mitochondrial dysfunction. Recent evidence has shown that enhancing FA utilization may provide cardioprotection against HF. Our aim was to investigate the effects and the underlying mechanisms of cardiac FA utilization on cardiac function in response to pressure overload. Methods and results: Transverse aortic constriction (TAC) was used in C57 mice to establish pressure overload-induced HF. TAC mice fed on a high fat diet (HFD) exhibited increased cardiac FA utilization and improved cardiac function and survival compared with those on control diet. Such cardioprotection could also be provided by cardiac-specific overexpression of CD36. Notably, both HFD and CD36 overexpression attenuated mitochondrial fragmentation and improved mitochondrial function in the failing heart. Pressure overload decreased ATP-dependent metalloprotease (YME1L) expression and induced the proteolytic cleavage of the dynamin-like guanosine triphosphatase OPA1 as a result of suppressed FA utilization. Enhancing FA utilization upregulated YME1L expression and subsequently rebalanced OPA1 processing, resulting in restoration of mitochondrial morphology in the failing heart. In addition, cardiac-specific overexpression of YME1L exerted similar cardioprotective effects against HF to those provided by HFD or CD36 overexpression. Conclusions: These findings demonstrate that enhancing FA utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing OPA1 processing in pressure overload-induced HF, suggesting a unique metabolic intervention approach to improving cardiac functions in HF.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29490017     DOI: 10.1093/cvr/cvy052

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.

Authors:  Huifeng Pi; Mengyu Liu; Yu Xi; Mengyan Chen; Li Tian; Jia Xie; Mingliang Chen; Zhen Wang; Min Yang; Zhengping Yu; Zhou Zhou; Feng Gao
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox.

Authors:  Matteo De Rosa; Jessica Gambardella; Jun Shu; Gaetano Santulli
Journal:  Cardiovasc Res       Date:  2018-06-01       Impact factor: 10.787

Review 3.  Heart failure in diabetes.

Authors:  Stanislovas S Jankauskas; Urna Kansakar; Fahimeh Varzideh; Scott Wilson; Pasquale Mone; Angela Lombardi; Jessica Gambardella; Gaetano Santulli
Journal:  Metabolism       Date:  2021-10-08       Impact factor: 8.694

Review 4.  Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease.

Authors:  Jianguo Lin; Jinlong Duan; Qingqing Wang; Siyu Xu; Simin Zhou; Kuiwu Yao
Journal:  Front Cardiovasc Med       Date:  2022-06-17

5.  Ketogenic diet aggravates cardiac remodeling in adult spontaneously hypertensive rats.

Authors:  Yuehua You; Yongzheng Guo; Ping Jia; Biaobiao Zhuang; Yu Cheng; Hongpei Deng; Xiaowen Wang; Cheng Zhang; Suxin Luo; Bi Huang
Journal:  Nutr Metab (Lond)       Date:  2020-10-26       Impact factor: 4.169

Review 6.  The Impact of Obesity on the Cardiovascular System.

Authors:  Imre Csige; Dóra Ujvárosy; Zoltán Szabó; István Lőrincz; György Paragh; Mariann Harangi; Sándor Somodi
Journal:  J Diabetes Res       Date:  2018-11-04       Impact factor: 4.011

7.  Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.

Authors:  Huaping Li; Jiahui Fan; Yanru Zhao; Xiaorong Zhang; Beibei Dai; Jiabing Zhan; Zhongwei Yin; Xiang Nie; Xiang-Dong Fu; Chen Chen; Dao Wen Wang
Journal:  Circ Res       Date:  2019-10-22       Impact factor: 17.367

8.  Pretreatment of Diabetic Adipose-derived Stem Cells with mitoTEMPO Reverses their Defective Proangiogenic Function in Diabetic Mice with Critical Limb Ischemia.

Authors:  Kun Lian; Qin Wang; Shuai Zhao; Maosen Yang; Genrui Chen; Youhu Chen; Congye Li; Haokao Gao; Chengxiang Li
Journal:  Cell Transplant       Date:  2019-11-05       Impact factor: 4.064

9.  Preserved Skeletal Muscle Mitochondrial Function, Redox State, Inflammation and Mass in Obese Mice with Chronic Heart Failure.

Authors:  Gianluca Gortan Cappellari; Aneta Aleksova; Matteo Dal Ferro; Antonio Cannatà; Annamaria Semolic; Michela Zanetti; Jochen Springer; Stefan D Anker; Mauro Giacca; Gianfranco Sinagra; Rocco Barazzoni
Journal:  Nutrients       Date:  2020-11-04       Impact factor: 5.717

10.  GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing.

Authors:  Yun Zhao; Jinyun Zhu; Ning Zhang; Qi Liu; Yingchao Wang; Xinyang Hu; Jinghai Chen; Wei Zhu; Hong Yu
Journal:  Stem Cells Transl Med       Date:  2020-06-09       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.